E233-1821 Screening compound: 2-[(3-chlorophenyl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

E233-1821 Screening compound: 2-[(3-chlorophenyl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide
E233-1821 Screening compound: 2-[(3-chlorophenyl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E233-1821
2-[(3-chlorophenyl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E233-1821

Molecular Formula

C26H32ClN5O2 (C26 H32 ClN5 O2)

Compound Name

2-[(3-chlorophenyl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-8-methyl-2H,4H,5H-furo[2,3-g]indazole-7-carboxamide

IUPAC name

2-[(3-chlorophenyl)methyl]-N-[2-(4-ethylpiperazin-1-yl)ethyl]-8-methyl-2H4H5H-furo[23-g]indazole-7-carboxamide

SMILES

CCN1CCN(CCNC(c2c(C)c(-c3nn(Cc4cccc(Cl)c4)cc3CC3)c3o2)=O)CC1

InChI

InChI=1S/C26H32ClN5O2/c1-3-30-11-13-31(14-12-30)10-9-28-26(33)25-18(2)23-22(34-25)8-7-20-17-32(29-24(20)23)16-19-5-4-6-21(27)15-19/h4-6,15,17H,3,7-14,16H2,1-2H3,(H,28,33)

InChI Key

HHBKGMSPODRSOE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14850678

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

482.03

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.228

Distribution Coefficient, logD

2.436

Water Solubility, LogSw

-3.87

Polar Surface Area

55.610

Acid Dissociation Constant (pKa)

13.07

Base Dissociation Constant (pKb)

8.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

E233-1821 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Immune system
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E233-1821 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E233-1821?
Check Price and Availability of E233-1821, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E233-1821 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E233-1821
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E233-1821
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E233-1821 available by request